oNKo-innate
Nicholas Huntington has a strong background in cancer immunology research and immunotherapy. Nicholas currently holds the position of Director of Research, Cancer Immunology at Monash University since February 2019. Prior to this, they co-founded oNKo-Innate Pty Ltd in April 2018, where they also served as the Chief Scientific Officer. From November 2011 to January 2019, they were the Head of the Immunotherapy Laboratory at The Walter and Eliza Hall Institute. Nicholas also gained experience as a Senior Scientist at Institut Pasteur from 2006 to 2011.
Nicholas Huntington completed their education from 1998 to 2006 at the University of Melbourne, where they obtained a Doctor of Philosophy (PhD) degree. Nicholas'sfield of study was Clinical/Medical Laboratory Science/Research and Allied Professions.
oNKo-innate
oNKo-innate is a discovery-stage biotechnology company dedicated to target identification and pre-clinical immuno-oncology drug development. With our deep understanding of Natural Killer (NK) cells, we aim to be the first to truly therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.